Episode 090: Prostate Cancer Series, Pt. 7- Treatment for Met. Castrate Resistant Prostate Cancer

The Fellow on Call: The Heme/Onc Podcast

Контент предоставлен Ronak Mistry and Rouleaux University Medical Center. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Ronak Mistry and Rouleaux University Medical Center или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.

9M ago

MP3•Главная эпизода

We made it to the end of another series. In our FINAL episode of the prostate cancer series, we turn our attention to metastatic castrate-resistant prostate cancer! We discuss treatment options, the data behind why we do what we do, and more targeted agents.

Content:

- Approach to metastatic castrate-resistant prostate cancer

- Refresher on what it means to be castrate-resistant

- Role of bisphosphate therapy and denosumab

- Treatment options and data surrounding sequencing of agents

- Other options for prostate cancer (radium-223 and lutetium-177-PSMA-617)

- Role of PARP inhibitors in BRCA-mutated disease

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

125 эпизодов

#Ronak Mistry #Rouleaux University Medical Center #Science #Fitness #Biology #Podcasting Education #Medicine #Lung Cancer